FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News

A visit from Montreal

On April 6th, 2017 Przemyslaw (“Mike”) Sapieha, PhD came to the Dept. of Ophthalmology of the University of Cologne as a Visiting Scientist in the German Research Foundation Research Unit FOR 2240 “Angiogenesis, Lymphangiogenesis and Cellular Immunity in Inflammatory Diseases of the Eye”. Dr. Sapieha is Director of the Neurovascular Eye Disease Lab and holds the Wolfe Professor in translational vision research at the Maisonneuve-Rosemont Hospital Research Centre, Montreal, Canada, and is Canada Research Chair in retinal cell biology. His talk was on the topic of “Cellular Senescence and Retinal Vascular Disease”.

Related posts

February 25, 2021

Eye clinic to win two renowned awards in the beginning of 2021


Read more
Zoom Meeting Shanghai

(v. l. n r.) Prof. Dr. med. Cursiefen, PD Dr. rer. nat. Felix Bock, Prof. Dr. med. Bi Yanglong Bi (top center)?), Prof. Dr. med. Takahiko Hayashi, PD Dr. med. Mario Matthaei

December 17, 2020

2nd Shanghai-Cologne Ophthalmic Research Meeting


Read more
November 6, 2020

FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program


Read more

News

  • Eye clinic to win two renowned awards in the beginning of 2021
  • German Ophthalmological Society (DOG) – Professor Dr. Claus Cursiefen elected as Secretary General
  • 2nd Shanghai-Cologne Ophthalmic Research Meeting
  • Antonia Howaldt accepted into the Cologne Clinician Scientist Program
  • FOR2240 Scientist Dr. Alexander C. Rokohl was selected for the Cologne Clinician Scientist Program

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck